PLSH (Panacea Life Sciences Holdings) Gross Profit: $0.51 Mil (TTM As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Panacea Life Sciences Holdings Gross Profit?

Panacea Life Sciences Holdings PLSH -25.00% Gross Profit is $0.51 Mil as of Sep. 2025. The stock has 6 warning signs investors should review.

Panacea Life Sciences Holdings's gross profit for the three months ended in Sep. 2025 was $0.05 Mil. Panacea Life Sciences Holdings's gross profit for the trailing twelve months (TTM) ended in Sep. 2025 was $0.51 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Panacea Life Sciences Holdings's gross profit for the three months ended in Sep. 2025 was $0.05 Mil. Panacea Life Sciences Holdings's Revenue for the three months ended in Sep. 2025 was $0.05 Mil. Therefore, Panacea Life Sciences Holdings's Gross Margin % for the quarter that ended in Sep. 2025 was 94.00%.

Panacea Life Sciences Holdings had a gross margin of 94.00% for the quarter that ended in Sep. 2025 => Durable competitive advantage

During the past 4 years, the highest Gross Margin % of Panacea Life Sciences Holdings was 59.12%. The lowest was 22.14%. And the median was 25.30%.

Panacea Life Sciences Holdings  (OTCPK:PLSH) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Panacea Life Sciences Holdings had a gross margin of 94.00% for the quarter that ended in Sep. 2025 => Durable competitive advantage

Panacea Life Sciences Holdings Gross Profit Related Terms

Panacea Life Sciences Holdings Gross Profit Historical Data

* Premium members only.

The historical data trend for Panacea Life Sciences Holdings's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Panacea Life Sciences Holdings Gross Profit Chart

Panacea Life Sciences Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Gross Profit
2.00 0.54 0.40 1.12

Panacea Life Sciences Holdings Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.72 0.73 0.28 0.18 0.05

PLSH vs SKYI, IMCC, CBDY: Gross Profit Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Panacea Life Sciences Holdings's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Panacea Life Sciences Holdings Gross Profit vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Panacea Life Sciences Holdings's Gross Profit distribution charts can be found below:

* The bar in red indicates where Panacea Life Sciences Holdings's Gross Profit falls into.


Panacea Life Sciences Holdings Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Panacea Life Sciences Holdings's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=2.385 - 1.263
=1.12

Panacea Life Sciences Holdings's Gross Profit for the quarter that ended in Sep. 2025 is calculated as

Gross Profit (Q: Sep. 2025 )=Revenue - Cost of Goods Sold
=0.05 - 0.003
=0.05

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.51 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Panacea Life Sciences Holdings's Gross Margin % for the quarter that ended in Sep. 2025 is calculated as

Gross Margin % (Q: Sep. 2025 )=Gross Profit (Q: Sep. 2025 ) / Revenue (Q: Sep. 2025 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.05 / 0.05
=94.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Profit →
What does a Gross Profit of $0.51 Mil mean?
Panacea Life Sciences Holdings (PLSH) has a Gross Profit of $0.51 Mil as of Sep. 2025. Gross Profit equals net sales less total cost of goods sold. View historical data on Panacea Life Sciences Holdings and its competitors.
Is Panacea Life Sciences Holdings' Gross Profit too high?
Panacea Life Sciences Holdings' current Gross Profit is $0.51 Mil.
How does Panacea Life Sciences Holdings' Gross Profit compare to SKYI and IMCC?
Panacea Life Sciences Holdings' Gross Profit of $0.51 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Drug Manufacturers company?
A good Gross Profit depends on the Drug Manufacturers industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Panacea Life Sciences Holdings and its competitors. Panacea Life Sciences Holdings's current Gross Profit is $0.51 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Panacea Life Sciences Holdings stock overvalued right now?
Panacea Life Sciences Holdings (PLSH) has a current Gross Profit of $0.51 Mil. The current Gross Profit is $0.51 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Panacea Life Sciences Holdings (PLSH), the current Gross Profit is $0.51 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Panacea Life Sciences Holdings Business Description

Address 5910 South University Boulevard, C18-193, Greenwood Village, CO, USA, 80121
Panacea Life Sciences Holdings Inc is a holding company organized as a plant-based natural health ingredient and product company, specializing in the development, manufacturing, research, and distribution of products and rapidly growing natural health and wellness market segment for both humans and animals. The company also offers the purest natural remedies within its branded product lines for every aspect of life: PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure and PANA Life.